» Articles » PMID: 23762860

A Comprehensive Tutorial on in Vitro Characterization of New Photosensitizers for Photodynamic Antitumor Therapy and Photodynamic Inactivation of Microorganisms

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2013 Jun 14
PMID 23762860
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro research performed on eukaryotic or prokaryotic cell cultures usually represents the initial step for characterization of a novel photosensitizer (PS) intended for application in photodynamic therapy (PDT) of cancer or photodynamic inactivation (PDI) of microorganisms. Although many experimental steps of PS testing make use of the wide spectrum of methods readily employed in cell biology, special aspects of working with photoactive substances, such as the autofluorescence of the PS molecule or the requirement of light protection, need to be considered when performing in vitro experiments in PDT/PDI. This tutorial represents a comprehensive collection of operative instructions, by which, based on photochemical and photophysical properties of a PS, its uptake into cells, the intracellular localization and photodynamic action in both tumor cells and microorganisms novel photoactive molecules may be characterized for their suitability for PDT/PDI. Furthermore, it shall stimulate the efforts to expand the convincing benefits of photodynamic therapy and photodynamic inactivation within both established and new fields of applications and motivate scientists of all disciplines to get involved in photodynamic research.

Citing Articles

Saliva-derived components can enhance the performance of toluidine blue in photodynamic therapy.

Macri N, Dias L, Pavarina A, Siqueira W, Sperandio F Front Pharmacol. 2025; 16:1538520.

PMID: 40017593 PMC: 11865188. DOI: 10.3389/fphar.2025.1538520.


Intracellular Fate of the Photosensitizer Chlorin e4 with Different Carriers and Induced Metabolic Changes Studied by H NMR Spectroscopy.

Vermathen M, Kampfer T, Nuoffer J, Vermathen P Pharmaceutics. 2023; 15(9).

PMID: 37765292 PMC: 10537485. DOI: 10.3390/pharmaceutics15092324.


Combinatorial Polydopamine-Liposome Nanoformulation as an Effective Anti-Breast Cancer Therapy.

Lu W, Liu W, Hu A, Shen J, Yi H, Cheng Z Int J Nanomedicine. 2023; 18:861-879.

PMID: 36844433 PMC: 9944797. DOI: 10.2147/IJN.S382109.


Multicomponent Molecular Systems Based on Porphyrins, 1,3,5-Triazine and Carboranes: Synthesis and Characterization.

Alpatova V, Rys E, Kononova E, Khakina E, Markova A, Shibaeva A Molecules. 2022; 27(19).

PMID: 36234729 PMC: 9572311. DOI: 10.3390/molecules27196200.


Parietin Cyclodextrin-Inclusion Complex as an Effective Formulation for Bacterial Photoinactivation.

Ayoub A, Gutberlet B, Preis E, Abdelsalam A, Abu Dayyih A, Abdelkader A Pharmaceutics. 2022; 14(2).

PMID: 35214089 PMC: 8875783. DOI: 10.3390/pharmaceutics14020357.


References
1.
Czekanska E . Assessment of cell proliferation with resazurin-based fluorescent dye. Methods Mol Biol. 2011; 740:27-32. DOI: 10.1007/978-1-61779-108-6_5. View

2.
Boyce J, Pittet D . Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control. 2002; 30(8):S1-46. DOI: 10.1067/mic.2002.130391. View

3.
Jori G, Fabris C, Soncin M, Ferro S, Coppellotti O, Dei D . Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med. 2006; 38(5):468-81. DOI: 10.1002/lsm.20361. View

4.
Jori G, Magaraggia M, Fabris C, Soncin M, Camerin M, Tallandini L . Photodynamic inactivation of microbial pathogens: disinfection of water and prevention of water-borne diseases. J Environ Pathol Toxicol Oncol. 2011; 30(3):261-71. DOI: 10.1615/jenvironpatholtoxicoloncol.v30.i3.90. View

5.
Agostinis P, Berg K, Cengel K, Foster T, Girotti A, Gollnick S . Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011; 61(4):250-81. PMC: 3209659. DOI: 10.3322/caac.20114. View